Log in to your Inderes Free account to see all free content on this page.
Initiator Pharma
3.14 SEK
+4.67 %
Less than 1K followers
INIT
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+4.67 %
+2.95 %
-16.93 %
-20.10 %
-54.16 %
-57.28 %
-47.14 %
-23.98 %
-30.00 %
Initiator Pharma is a biotechnology company developing drug candidates for diseases of the central and peripheral nervous system. The company's main business focus is on the development of drug candidates used in the treatment of erectile dysfunction in men. Initiator Pharma was founded through a spin-off from the company Saniona and is headquartered in Denmark.
Read moreMarket cap
214.94M SEK
Turnover
195.25K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.2.
2026
Annual report '25
8.5.
2026
Interim report Q1'26
29.5.
2026
General meeting '26
All
Press releases
ShowingAll content types
Redeye: Initiator Pharma (Q3 review) - Back in the clinic
Correction: INITIATOR PHARMA: Q3 2025 REPORT
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio